BSE+-+initiating+coverage-Jan-25-NUVAMA
BSE+-+initiating+coverage-Jan-25-NUVAMA
BSE+-+initiating+coverage-Jan-25-NUVAMA
Ini a ng Coverage
BSE LIMITED
Rising Star: Throwing down the gauntlet
BSE
INITIATING COVERAGE
KEY DATA
Rating BUY
Rising Star: Throwing down the gauntlet
Sector relative Neutral
Price (INR) 5,157
12 month price target (INR) 6,730 BSE—Asia’s oldest stock exchange—is highly adaptive and shall thrive
52 Week High/Low
Market cap (INR bn/USD bn)
5,838/1,941
698/8.1
despite tighter index derivatives regulation. Think fast and slow—fast
Free float (%) 100.0 picture: discontinued weekly contracts make up 21.3% of its ADPTV;
Avg. daily value traded (INR mn) 13,490.3
the slow one: immense scope to grow customer base (merely 1.5–2mn
currently). Plus, higher contract sizes shall reduce clearing charges,
SHAREHOLDING PATTERN thereby lifting EBITDA margin. Longer term, diverse revenue streams
Sep-24 Jun-24 Mar-24 (StAR MF, AIPL, colocation services) shall amplify growth potential.
Promoter 13.01% 11.12% 13.04%
FII 11.68% 11.60% 12.69%
Even after building in the hit from regulatory changes, we forecast BSE
DII 52.40% 54.52% 51.91% shall turn in an FY24–27E revenue/APAT CAGR of 39.9%/70.8%, lifting
Pledge - - - its RoE to 37.9%. Initiate at ‘BUY’ with a TP of INR6,730 based on FY27E
PE of 50x (given duopolistic industry) plus the value of its stake in CDSL.
FINANCIALS (INR mn) Beyond noise: Derivatives to scale up despite regulatory tightening
Year to March FY24A FY25E FY26E FY27E
We believe BSE is better equipped to face the impact of changes in market structure
Revenue 13,900 27,558 32,904 38,053
EBITDA 3,997 13,785 18,702 21,914
brought about by SEBI’s Nov-24 circular reforming the index derivatives market. We
Adjusted profit 3,484 11,124 14,902 17,367 argue BSE can continue to grow index option volumes considering that discontinued
Diluted EPS (INR) 25.4 81.0 108.5 126.5 contracts comprise only 21.3% of its index option premium volumes (ADPTVs) versus
EPS growth (%) 107.1 219.3 34.0 16.5 NSE’s 46.9%. The full force of the impact shall only be known after all changes—
RoAE (%) 11.6 31.7 37.4 38.0
increased lot sizes and margin requirements—kick in by Jan-25. Moreover, BSE has
P/E (x) 187.6 58.8 43.9 37.6
EV/EBITDA (x) 288.0 65.9 47.2 40.0
room to expand its derivatives active customer base—currently 1.5mn–2mn
Dividend yield (%) 0.3 1.2 1.6 1.9 (monthly) versus NSE’s 4.2mn. In all, we estimate BSE’s equity index option ADPTV
market share shall burgeon to 14.9% in FY27E from 3.1% in FY24 (already 11.9% in
Nov-24). BSE has hiked transaction charges from INR500 per INR10mn to INR3,250.
Growing volumes along with higher transaction charges are likely to fire FY24–27E
PRICE PERFORMANCE
transaction charges CAGR of 69.9%.
5,800 86,000
5,030 82,800 A nuanced trade: Lower clearing charges to send margins soaring
4,260 79,600
3,490 76,400
We reckon increased contract sizes shall not have a significant impact on BSE’s
2,720 73,200 ADPTV as its average number of contracts traded/order is five. That said, we expect
1,950 70,000 higher contract sizes to result in lower clearing charges as clearing charges are
Jan-24 Apr-24 Jul-24 Oct-24
BSE IN EQUITY Sensex
calculated on the number of contracts cleared, which is likely to reduce. Hence,
clearing charges shall drop from INR2,013 per INR10mn of premium turnover in FY24
to INR734 by FY26E, contributing to EBITDA margin expansion over FY24–27E.
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Executive Summary
Established in 1875 on Dalal Street in Mumbai, BSE Ltd (formerly Bombay Stock
Exchange) is the oldest stock exchange of Asia. The stock exchange provides
investors a trading platform to purchase and sell equity and fixed-income securities
listed on the stock exchange. BSE provides an efficient and transparent market for
trading in equity, currencies, debt instruments, derivatives and mutual funds. Indian
Clearing Corporation Ltd—a wholly-owned subsidiary of BSE—acts as the central
counterparty to all trades executed on the BSE trading platform.
BSE SME is India’s largest SME platform with over 480 companies listed and
continues to grow at a steady pace. BSE StAR MF is India’s largest online mutual fund
platform, which processed over 420mn transactions and added 27.1mn new SIPs in
FY24. The company has a diversified revenue stream comprising transaction
charges, listing services, treasury income, index services, data feed and others.
2 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Financial outlook
Transaction revenue is likely to increase at a blistering CAGR of 69.9% over FY24–
27E to INR22bn, contributing 58% to total revenue. We anticipate BSE to sustain
strong revenue growth despite near-term regulatory changes, with an estimated
operating revenue CAGR of 39.9% over FY24–27E. Alongside, we forecast EBITDA
margin shall improve 2,879bp from FY24 to 57.6% by FY27E, driving an EBITDA CAGR
of 76.3% over FY24–27E. APAT margin is likely to jump 2,055bp over FY24’s to 45.6%
by FY27E. We forecast RoE would expand to 37.9% by FY27 from the current 11.6%.
Valuation
We are initiating coverage on BSE with a ‘BUY’ and TP of INR6,730 based on target
PE of 50x FY27E EPS plus value of its stake in CDSL. We believe a 50x PE for the
company is apt given duopolistic nature of the industry, and relative valuation of
Indian capital market infrastructure plays such as CDSL, KFINTECH, MCX and CAMS.
We add the value of CDSL to our TP of INR1,740, valuing CDSL at a market
capitalisation of INR363.6bn. BSE owns a 15% stake in CDSL, implying the value of
stake at INR54.5bn and contributing 5.9% to our TP.
Our TP implies upside potential of 30%. At the CMP of INR5,157, the stock is trading
at FY26E/27E P/E of 43.9x/37.6x and EV/NOPLAT of 47.2x/40.0x.
Key risks
Any change in regulations or any adverse regulatory actions can have a material
impact on the business and may result in earnings volatility.
Competition risk arising from the launch and success of new exchange/s.
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 3
BSE
12 11.4 20 18.6
15.5
9 15
(INR bn)
(%)
6 10
3.1 4.5
3 5
1.6
0 0
FY24 FY25E FY26E FY27E FY23 FY24 FY25E FY26E FY27E
Transaction charges revenue share to dominate Revenue likely to rise at 39.9% CAGR over FY24–27E
100 6.3 5.9 5.7 40 98.3 100.0
9.4 2.5 2.4 2.4
3.1 2.7 2.7 2.4
3.4 12.2 12.6 12.8 38.0
80
20.2 3.7 4.5 4.5 32 80.0
8.3 7.9 7.5 33.1
60 9.1 8.2 7.4 6.7 70.4
27.8
(%)
9.2 24 60.0
(INR bn)
40 13.2
56.2 56.5 57.9 16 40.0
20
32.3
8.2 13.9
0 8 19.4 20.0
15.7
FY24 FY25E FY26E FY27E 9.7
Transaction Charges Treasury Income 0 0.0
MF revenue C&S Charges FY23 FY24 FY25E FY26E FY27E
Listing Fees Book Building Revenue (INR bn) YoY growth (%)
EBIT FY24–27E CAGR: 88.3% APAT FY24–27E CAGR at 70.8% with RoE at 30%-plus
25 60 20 40
37.6 37.9
53.1 53.4
20 48 16 32.1 17.3 32
46.3 20.3
15.0
15 17.5 36 12 24
(INR bn)
(INR bn)
(%)
(%)
11.3
12.9 8 16
10 24
21.9
11.6
16.8
4 8
5 12 6.3
1.7 3.5
1.4 3.0 0 0
0 0
FY23 FY24 FY25E FY26E FY27E
FY23 FY24 FY25E FY26E FY27E
EBIT (INR bn) EBIT margin (%) APAT (INR bn) RoE (%)
4 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Financial Statements
Income Statement (INR mn) Balance Sheet (INR mn)
Year to March FY24A FY25E FY26E FY27E Year to March FY24A FY25E FY26E FY27E
Total operating income 13,900 27,558 32,904 38,053 Share capital 271 271 271 271
Gross profit 0 0 0 0 Reserves 32,752 36,931 42,318 48,616
Employee costs 2,047 2,365 2,649 2,914 Shareholders funds 33,023 37,202 42,589 48,887
Other expenses 7,856 11,408 11,553 13,225 Minority interest 1,524 1,474 1,429 1,388
EBITDA 3,997 13,785 18,702 21,914 Borrowings 9,576 10,616 11,779 13,080
Depreciation 954 1,149 1,313 1,558 Trade payables 1,906 2,643 3,155 3,649
Less: Interest expense 151 0 0 0 Other liabs & prov 48,364 56,107 60,800 65,539
Add: Other income 2,279 2,201 2,424 2,753 Total liabilities 94,502 108,159 119,881 132,683
Profit before tax 5,171 14,837 19,812 23,109 Net block 1,991 2,513 2,595 2,751
Prov for tax 1,847 3,798 4,993 5,823 Intangible assets 862 1,396 1,645 1,834
Less: Other adj 4,300 842 917 1,088 Capital WIP 145 158 172 187
Reported profit 7,784 11,965 15,819 18,455 Total fixed assets 2,998 4,067 4,413 4,772
Less: Excp.item (net) 4,300 842 917 1,088 Non current inv 11,522 11,252 11,003 10,772
Adjusted profit 3,484 11,124 14,902 17,367 Cash/cash equivalent 44,629 60,059 68,411 76,552
Diluted shares o/s 137 137 137 137 Sundry debtors 2,109 3,024 4,335 6,216
Adjusted diluted EPS 25.4 81.0 108.5 126.5 Loans & advances 550 577 606 636
DPS (INR) 15.0 56.7 76.0 88.5 Other assets 13,000 12,924 12,882 12,872
Tax rate (%) 35.7 25.6 25.2 25.2 Total assets 94,502 108,159 119,881 132,683
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 5
BSE
Investment Rationale
BSE is likely to be less hurt by a reduction in weekly contract volumes as
discontinued contracts are 21.3% of its index option premium volumes in year
to FY25 versus NSE’s 46.9%. The complete impact shall only be known after all
changes—higher lot sizes and margin requirements kick in, in Jan-25.
We believe BSE has room to grow its derivative active customer base, which is
at 1.5mn–2mn (monthly) in Nov-24 versus NSE’s 4.2mn; moreover, given that
only one expiry day per week per exchange is now allowed, it is possible that at
least part of the investor base at NSE also starts trading on the BSE.
BSE’s equity index option ADPTV market share to improve to 14.9% in FY27E
from 3.1% in FY24; its equity index ADPTV market share has already risen to
11.9% in Nov-24. BSE has hiked transaction charges to INR3,250/INR10mn from
INR500. Growing volumes along with increased transaction charges are likely to
result in strong growth in transaction charges.
We reckon higher contract sizes are unlikely to hurt BSE’s volumes materially as
average number of contracts traded/order is five; moreover, we expect higher
contract sizes to lower clearing charges. We build in a fall in clearing charges
from INR2,013/INR10mn of premium turnover in FY24 to INR734 by FY26E. This
is likely to result in EBITDA margin expansion to 57.6% in FY27E from 28.8% in
FY24.
Other revenue drivers include StAR MF, AIPL and growth in colocation charges.
As a result of these changes, NSE and BSE had to reduce their offerings and also
increase contract sizes. While we do forecast some reduction in volumes, we also
estimate some shift in volumes from one contract to the other at and near expiry
and investors becoming more active on both exchanges at and near expiries as only
limited days of the week are set to be expiry days and available to trade.
6 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
NSE’s index options expiry days changed from Monday–Friday to Thursday with increase in lot sizes
Underlying Period Old expiry New expiry Lot size Expiry Date
Last expiry date New contracts First expiry date
Old New
with existing lot size available from with revised lot size
Quarterly,
Semi- Last Thursday of month Last Thursday of month 25 75 26-Dec-24 26-Dec-24 27-Mar-25*
Nifty annual
Monthly Last Thursday of month Last Thursday of month 25 75 30-Jan-25 28-Nov-24 27-Feb-25
Weekly Thursdays Thursday every week 25 75 19-Dec-24 28-Nov-24 2-Jan-25
Last Wednesday of
Quarterly Last Thursday of month 15 30 24-Dec-24 24-Dec-24 26-Mar-25**
expiry month
Bank Nifty Last Wednesday of
Monthly Last Thursday of month 15 30 29-Jan-25 27-Nov-25 26-Feb-25
expiry month
Weekly Wednesdays Contract disallowed 15 NA 13-Nov-24 NA NA
Last Tuesday of expiry
Monthly Last Thursday of month 25 65 28-Jan-25 26-Nov-24 25-Feb-25
FINNIFTY month
Weekly Every Tuesday Contract disallowed 25 NA 18-Nov-24 NA NA
Last Monday of expiry
Monthly Last Thursday of month 50 120 27-Jan-25 25-Nov-24 24-Feb-25
MIDCPNIFTY month
Weekly Mondays Contract disallowed 50 NA 19-Nov-24 NA NA
Last Friday of expiry
Monthly Last Thursday of month 10 25 31-Jan-25 29-Nov-24 28-Feb-25
NIFTYNXT50 month
Weekly Fridays Contract disallowed 10 NA 22-Nov-25 NA NA
Source: NSE, Nuvama Research
Mar-25 contracts introduced as quarterly contracts; to become far month contract of respective index derivative on Dec-24 monthly expiry day (EoD)
BSE’s index options expiry days changed from Friday and Monday to Tuesday with increase in lot size
Underlying Period Old expiry New expiry Lot size Expiry Date
Last expiry date
New contracts First expiry date
Old New with existing lot
available from with revised lot size
size
Quarterly,
Last Friday of month Last Tuesday of month 10 20 27-Dec-24 27-Dec-24 28-Mar-25*
Semi-annual
Sensex Monthly Last Friday of month Last Tuesday of month 10 20 31-Jan-25 29-Nov-24 28-Feb-25
Weekly Fridays Tuesdays 10 20 3-Jan-25 6-Dec-24 10-Jan-25
Last Monday of expiry
Monthly Last Tuesday of month 15 30 27-Jan-25 25-Nov-24 24-Feb-25
Bankex month
Weekly Mondays Contract disallowed 15 NA 18-Nov-24 NA NA
Last Thursday of expiry
Monthly Last Tuesday of month 25 60 30-Jan-25 28-Nov-25 27-Feb-25
SENSEX50 month
Weekly Thursdays Contract disallowed 25 NA 14-Nov-24 NA NA
Source: BSE, Nuvama Research
Moreover, SEBI has also removed calendar spread treatment on expiry day i.e. the
benefit of offsetting positions across different expiries (calendar spread) shall not be
available on the day of expiry for contracts expiring on that day, thereby resulting in
increased margin requirements. Lastly, SEBI has required exchanges to monitor
intra-day position limits.
We believe these measures shall strengthen the industry in the longer term although
in the short term these measures may result in an adverse impact on volumes.
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 7
BSE
40
35.1 NSE premium T/V (%)
32
26.1
24
(%)
16 12.5
10.7
8.3
8
3.6 2.7
1.1
0
Monthly Weekly Monthly Weekly Monthly Weekly Monthly Weekly
BANKNIFTY NIFTY MIDCPNIFTY FINNIFTY
36
(%)
24 21.3
14.9
12 7.6
0
Monthly Weekly Monthly Weekly
BANKEX SENSEX
Source: BSE, Nuvama Research
On the NSE, equity index option contracts trading is more prevalent on non-expiry
days compared with contracts that get traded on the BSE. Only ~30% of premium
turnover is traded on expiry day for the Nifty 50 options, whereas 84.1% of total
premium is traded on expiry day for Sensex options.
8 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
50
40
32.4
30
30.0
(%)
20 18.5 15.8 15.4
12.2
BANKNIFTY NIFTY
100 91.5
84.1 Premium turnover (%)
80
60
40
20
8.6
1.6 3.5 4.0 2.1 2.9 1.5 2.3
0.5 0.8 0.2 0.5
0
0DTE 1DTE 2DTE 3DTE 4DTE 5DTE 5+DTE
BANKEX SENSEX
Depth in NSE’s traded equity index option volumes is also exhibited by the fact that
a large percentage (20%-plus) of Nifty index option volumes are traded about a
month i.e. 15–35 days to expiry bucket.
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 9
BSE
NSE depth with 20%-plus premium T/V over 15–35 days to expiry bucket
60
Premium T/V (%)
48 44.5
35.6
36
(%)
26.6
24
25.3 17.2 15.3
10.3
12 6.4 7.0
3.9 5.1
2.1
0.1 0.6
0
0DTE 1DTE 2-7DTE 8-15DTE 16-35DTE 36-65DTE 65+DTE
BANKNIFTY NIFTY
As of Sep-24, BSE had 5.6mn activated accounts on the derivatives segment. NSE’s
annual reported derivative segment active customers is 9.2mn, whereas derivative
segment monthly active customers is ~4.2mn as of Nov-24. We understand from
discussions with the company that monthly active customers for the BSE is still in
the range of 1.5mn–2mn. Given NSE now offers only a single expiry a day traders
may move to BSE. BSE has also moved expiry to Tuesday so as to have a clear three
trading days from NSE’s Thursday.
Note: Change with respect to last five-week average (11th Oct- 8th Nov) before
implementation of SEBI’s circular on changes in equity index derivatives dt. 01/10/2024
10 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
0
May-23 Aug-23 Nov-23 Feb-24 May-24 Aug-24 Nov-24
NSE BSE
15 200
155.4
12 160
9 120
(INR bn)
(%)
70.4
6 80
48.2
3 9.7 40
0.0 11.3
4.5 5.0 7.4 8.2 13.9 13.5
0 0
FY20 FY21 FY22 FY23 FY24 H1FY25
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 11
BSE
150
120
90
(INR bn)
60 121.2
101.7
69.7 71.8
30
42.4 5.8 9.1
23.91.1 1.4 2.6 2.4
0
FY20 FY21 FY22 FY23 FY24 H1FY25
NSE BSE
20 34.8 41.9
25.1 27.7 29.6
0
FY20 FY21 FY22 FY23 FY24
Transaction charges BSE Listing services BSE
Income on investments BSE Data services BSE
Clearing & Settlement Services BSE Others BSE
Source: BSE, Nuvama Research
Cash equity: Indian cash equity ADTV has grown at a CAGR of 20.8% in FY14–24 to
INR883bn in FY24. During FY25TD, cash ADTV has further increased to INR1.29tn
(+76.1% YoY). During year to FY25, BSE’s market share was 6.7%. We are not building
in a substantial increase in market share for BSE in the cash equities segment.
12 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
1,500 1,470 10
1,278
1,157
1,200 8
7.5 7.5
7.0
817 6.5 6.5 6.5
900 6
(INR bn)
668
(%)
548
600 4
300 2
54 66 81 89 102
41
0 0
FY22 FY23 FY24 FY25E FY26E FY27E
Derivatives: Indian equity index futures along with single stock futures and options
segments remains dominated by NSE with BSE holding almost no market share. BSE
however has done well in the equity index options segment.
Indian equity index options average daily premium turnover has grown at a CAGR of
81.3% in FY19–24 to INR638tn in FY24 and now stands at INR759tn in FY25TD (Nov-
24). BSE—which started in this segment just in May-23—has been able to capture a
market share of 11.9% (Nov-24). We reckon some improvement in market share
over the course of FY26 and are then building in stable shares.
BSE gaining MS in options trading post-launch of weekly contracts
Premium turnover market share
100 0.0 0.5 2.3 3.7 4.6 7.2 9.7 9.8 13.3 11.9
80
60
(%)
100.0 99.5 97.7 96.3 95.4 92.8 90.3 90.2 86.7 88.1
40
20
0
Jul-24
Jul-23
May-23
Nov-23
May-24
Nov-24
Sep-23
Jan-24
Mar-24
Sep-24
NSE BSE
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 13
BSE
12 11.4
(%)
6
3.1
3
0
FY24 FY25E FY26E FY27E
14 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
1,281
1400
786 724 796
639
700 447 504 411
341 265
94 185
57
0
FY20 FY21 FY22 FY23 FY24 FY25E FY26E FY27E
Number of Orders (mn) MF Revenue (INR mn)
Source: Company, Nuvama Research
100 89
67
50
0
Q2FY22 Q4FY22 Q2FY23 Q4FY23 Q2FY24 Q4FY24 Q2FY25
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 15
BSE
16 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 17
BSE
Valuations
Initiate coverage at ‘BUY’ and a TP of INR6,730 (30% upside potential) i.e. FY27E
P/E of 50x + value of 15% stake in CDSL.
We are initiating coverage on BSE with a ‘BUY’ and TP of INR6,730 based on target
valuation of 50x FY27E EPS plus value of its stake in CDSL. We believe a 50x PE for
the company is apt given duopolistic nature of the industry, and relative valuation
of Indian capital market infrastructure plays such as CDSL, KFINTECH, MCX and
CAMS. We add the value of CDSL to our TP of INR1,740 valuing CDSL at a market
capitalisation of INR363.6bn. BSE owns a 15% stake in CDSL, implying value of stake
at INR 54.5bn, and contributing 5.9% to our TP.
Our TP implies upside potential of 30%. Our TP of INR6,730 implies target valuation
of FY26E/27E P/E of 58.4x/50.1x and EV/NOPLAT of 63.8x/54.2x. At the CMP of
INR5,157, the stock is trading at FY26E/27E P/E of 43.9x/37.6x and EV/NOPLAT of
47.2x/40.0x.
TP of INR6,730 at 50x FY27E EPS + value of CDSL at TP of INR1,740
Particulars (INR bn)
FY27E APAT (ex-CDSL) 17.3
Multiple (x) 50
Core business market cap 868.3
Add: CDSL stake (15%) 54.5
Market Cap 922.8
Valuation (INR/share) 6,730
CMP (INR/share) 5,157
Upside (%) 30
Source: Company, Nuvama Research
BSE trading at a 1Y forward P/E, which is more than +1 standard deviation of its historical trading averages
BSE 1yr forward P/E
65
52
39
(x)
26
13
0
Oct-19 Apr-20 Oct-20 Apr-21 Oct-21 Apr-22 Oct-22 Apr-23 Oct-23 Apr-24 Oct-24
1 Year forward P/E Average P/E -1 SD +1 SD
18 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Valuations comps- Indian financial infra companies such as CDSL, KFIN, MCX, CAMS and BSE trading at high valuations
Mkt. Cap FY24-27E CAGR P/E P/B RoE EBITDA Margin (%)
Company Name CMP TP Rating
(INR bn) EPS Revenue FY25E FY26E FY27E FY25E FY26E FY27E FY25E FY26E FY27E FY25E FY26E FY27E
Asset Management
HDFC Asset
3,835 5,150 Buy 819.7 17.2 18.9 33.3 30.1 26.2 10.2 9.2 8.2 32.5 32.1 33.0 78.9 80.1 80.8
Management Co Ltd
Nippon Life India
636 880 Buy 402.9 17.7 19.8 28.2 25.6 22.1 9.1 7.7 6.4 33.9 32.5 31.6 64.6 66.7 68.9
Asset Manage
Aditya Birla Sun Life
725 900 Hold 209.0 10.8 13.1 21.9 21.2 19.7 5.7 5.1 4.5 28.1 25.4 24.1 57.9 57.9 58.3
Asset Ma
UTI Asset
1,184 1,510 Buy 151.5 9.4 15.3 19.4 16.4 15.0 3.2 2.9 2.7 17.0 18.6 18.7 47.6 48.8 49.4
Management Co Ltd
Broking
Prudent Corporate
2,661 3,270 NR 110.2 39.2 31.0 51.0 38.5 29.9 16.0 11.4 10.0 37.0 34.9 32.7 24.9 26.2 27.5
Advisory Ser
Angel One Ltd 2,447 3,434 NR 220.8 20.7 28.5 16.2 14.5 10.9 4.0 3.3 2.7 32.5 24.7 27.0 33.8 34.4 36.6
Nuvama Wealth
6,108 7,928 NR 219.1 23.7 22.1 23.8 21.6 18.8 6.4 5.5 4.8 29.9 28.6 28.3 53.1 51.8 50.2
Management Ltd
360 ONE WAM Ltd 1,102 1,221 NR 427.9 21.4 20.5 40.3 34.4 29.3 9.0 7.9 7.2 26.0 25.9 27.9 50.5 53.1 53.0
Motilal Oswal
826 1,060 NR 495.2 35.6 25.9 15.5 18.4 11.7 4.0 3.1 2.4 20.1 18.8 18.2 56.3 56.5 55.9
Financial Servic
Exchange
BSE Ltd 5,157 6,730 Buy 708.1 70.8 39.9 58.8 43.9 37.6 19.5 16.8 14.5 31.7 37.4 38.0 50.0 56.8 57.6
Multi Commodity
5,567 6,563 NR 283.9 111.3 33.4 48.3 37.6 31.6 17.4 14.7 12.3 38.3 41.4 40.8 62.6 65.5 66.7
Exchange of In
Depository
Central Depository
1,529 1,740 Hold 319.6 21.4 20.5 56.0 49.8 42.7 18.6 15.9 13.6 35.9 34.4 34.4 61.5 62.4 64.0
Services In
Computer Age
4,282 5,250 Hold 211.4 25.0 17.3 45.4 38.0 32.2 20.4 17.2 14.6 48.7 49.2 49.2 46.4 48.5 49.7
Management Servic
Kfin Technologies Ltd 1,255 1,400 Hold 215.7 21.8 17.9 65.3 57.8 48.5 16.1 13.8 11.8 26.7 25.8 26.3 44.3 45.5 46.1
Source: Company, Nuvama Research, Bloomberg; Note; NR = not rated; For not rated stocks Bloomberg estimates have been used.
BSE clocks five-year EBITDA CAGR of 82.6%; delivering PAT margin of 25.1%
FY Revenue 5-Y CAGR EBITDA 5-Y CAGR PAT 5-Y CAGR EBITDA margin PAT margin
Exchanges RoE (%)
Ending (FY24) (%) (FY24) (%) (FY24) (%) (%) (%)
USA
ICE Dec 7,968 8.9 5,242 9.3 3,161 7.6 65.8 39.7 12.4
NASDAQ Dec 3,842 8.7 2,136 10.2 1,403 11.1 55.6 36.5 20.7
Europe
LSE Dec 10,128 27.4 4,800 24.4 2,273 20.0 47.4 22.4 6.9
DBG Dec 5,433 11.4 3,166 9.9 1,934 9.9 58.3 35.6 19.7
Asia
HKEX Dec 2,647 4.7 1,953 4.4 1,521 4.6 73.8 57.4 23.2
JPX Mar 953 -2.7 648 -1.9 372 -3.3 68.0 39.1 13.8
NSE Mar 1,786 33 1,192 34.1 1,005 37.5 66.8 55.8 38.1
SGX Jun 859 5.7 483 5.5 360 5.3 56.2 41.9 30.7
BSE Mar 168 21.1 48 82.6 42 10.3 28.8 25.1 11.6
Canada
TMX Dec 886 8.0 484 6.9 299 6.4 54.6 33.7 9.7
Oceania
ASX Jun 681 3.1 424 -0.7 314 -1.2 62.3 46.1 13.1
Source: Bloomberg, Nuvama Research Note: All numbers are in USD mn ICE, LSE, DBG, HKEX, Nasdaq, TMX- FY ending is CY ending in Dec
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 19
BSE
Indian exchanges likely to trade at higher valuations due to higher growth and return ratio expectations
Mkt. Cap FY24-27E CAGR P/E P/B ROE (%) EBITDA Margin (%)
Company Name
(USD bn) EPS Revenue FY25E FY26E FY27E FY25E FY26E FY27E FY25E FY26E FY27E FY25E FY26E FY27E
Intercontinental
82.0 10.1 9.3 25.5 23.6 21.4 19.1 3.1 3.0 2.8 2.7 12.4 12.2 12.1 12.9
Exchange
London Stock Exchange
75.3 11.1 7.1 34.3 32.1 28.4 25.0 2.4 2.6 2.5 2.4 6.9 8.0 8.1 9.1
Group PL
Deutsche Boerse AG 43.4 5.5 6.2 22.4 21.3 20.4 19.1 4.2 3.9 3.5 3.1 19.7 18.7 17.4 16.8
Hong Kong Exchanges &
44.8 6.3 6.4 29.4 27.0 25.7 24.5 6.7 6.6 6.4 6.1 23.2 24.6 25.1 25.5
Clearing
Nasdaq 43.6 8.6 12.3 27.0 27.0 24.3 21.1 6.8 3.9 3.8 3.5 20.7 14.9 15.2 15.9
Japan Exchange Group 11.3 4.4 5.9 30.3 28.7 27.6 26.7 NA NA NA NA 13.8 18.7 18.8 19.3
TMX Group 8.3 10.1 9.2 27.5 26.2 23.1 20.6 2.7 2.6 2.5 2.4 9.7 9.6 10.5 11.0
ASX 7.6 1.2 3.1 24.1 24.7 24.2 23.3 3.2 3.2 3.1 3.1 13.1 13.1 11.8 12.2
Singapore Exchange 9.4 8.1 5.6 26.8 23.5 21.7 21.2 7.8 6.9 6.0 5.5 30.7 28.9 27.2 26.1
BSE 8.2 51.9 42.3 118.9 56.9 44.8 33.9 20.6 17.0 14.1 12.1 15.6 35.3 39.5 43.0
Source: Bloomberg, Nuvama Research
Note: ICE, LSE, DBG, HKEX, Nasdaq, TMX- financial year implies calendar year i.e. FY25E is CY24 and so on.
20 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Financial Outlook
We reckon share of transaction charges shall increase substantially to 58% of
total revenue by FY27E from 32.3% in FY24.
FY24–27E CAGR: Revenue - 39.9%, EBITDA - 76.3% and APAT (ex- CDSL) - 70.8%.
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 21
BSE
15 17.5 36
(INR bn)
(%)
12.9
10 24
21.9
16.8
5 12
1.4 3.0
0 0
FY23 FY24 FY25E FY26E FY27E
22 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
APAT CAGR of 70.8% over FY24–27E with likely RoE of 37.9% in FY27E
20 40
37.6 37.9
16 32.1 17.3 32
15.0
12 24
(INR bn)
(%)
11.3
8 16
11.6
4 8
6.3
1.7 3.5
0 0
FY23 FY24 FY25E FY26E FY27E
APAT (INR bn) RoE (%)
19.8
8.0 15.3 17.3 15.1 16.2 80.0
(INR bn)
(%)
71.9
46.0 42.6
- -
FY22 FY23 FY24 FY25E FY26E FY27E
(8.6)
(8.0) (80.0)
(96.5)
(16.0) (160.0)
FCFE FCFE as % of revenue (%)
Source: Company, Nuvama Research
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 23
BSE
Key Risks
Changing regulations and any adverse regulatory action: SEBI extensively regulates
exchanges in India. Any change in regulations can have a material impact on business
growth, market share and/or result in significant changes in costs. Examples include
changes in expiry days and lot sizes for index options, elevated margin requirements
and increased contribution requirements towards core SGF. Such changes may lead
to earnings volatility. Our view is that the impact of recent regulatory changes is
lower on BSE compared with NSE.
Dependence on index options in derivative segment: Even though BSE offers single
stock futures and options, it has not yet gained significant traction. Its major income
from the derivative segment is just through index options. A slowdown in growth in
this segment may affect earnings significantly.
Any large-scale macro slowdown: A large broad scale economic slowdown may hurt
capital market sentiments and affect trading volumes. Given that transaction
charges shall account for 58% of BSE’s consolidated revenue, a slowdown in trading
activity may result in a sharp decline in revenue and earnings.
Launch and success of new exchange/s: As exchanges are now allowed to offer
index derivative products expiring only on one day a week, there is a possibility new
exchanges could be set up to provide products on days not taken up by other
exchanges. This may affect future growth of volumes at BSE.
Interest rate risk: Its investments are exposed to the effects of fluctuations in market
interest rates; hence, declines in interest rates may adversely affect its value.
24 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Company Description
BSE was established as ‘The Native Share & Stock Brokers' Association’ in 1875 and
was the first stock exchange in Asia. It is the fastest stock exchange in the world with
a speed of 6 microseconds. BSE became the first listed stock exchange in India in
2017. The exchange provides an efficient and transparent market for trading in
equity, currencies, debt instruments, derivatives and mutual funds. Indian Clearing
Corporation Ltd, a wholly-owned subsidiary of BSE, acts as the central counterparty
to all trades executed on the BSE trading platform.
BSE SME is India’s largest SME platform, with over 480 companies listed and
continues to grow at a steady pace. BSE StAR MF is India’s largest online mutual fund
platform, which processed over 420mn transactions and added 27.1mn new SIPs in
FY24.
BSE has a diversified revenue stream comprising transaction charges, listing services,
treasury income, index services, data feed and others.
Brief timeline of BSE’s development over the decades
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 25
BSE
26 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Management Overview
Mr Sundararaman Ramamurthy, MD & CEO
Mr Ramamurthy is a highly motivated leader and consistent performer with a
successful track record of 38 years and strong passion to lead a financial institution.
He is a Cost Accountant and member of the Indian Institute of Bankers.
Academically, Mr Ramamurthy is a Bachelor of Science. He was the MD & Chief
Operating Officer of the Indian arm of Bank of America (BANA), where his
responsibilities included global governance and control of the banking entity in India
and the securities segment.
With over 20 years of work experience at NSE and as a senior member of the NSE
team since its inception, he was responsible for significant transformation of the
Indian capital markets for over two decades. He has also worked with leading public
sector banks, viz. Industrial Development Bank of India, State Bank of India and
Indian Overseas Bank.
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 27
BSE
Board of Directors
Name Designation Others
Prof. Subhasis Chairman (Public
Currently Chair Professor at K.N. Bajaj, Former Director of IIT Bombay
Chaudhuri Interest Director)
Mr Sundararaman
MD & CEO Former MD & COO in Indian arm of Bank of America (BANA), 20 years at NSE as a senior member
Ramamurthy
Former consultant advisor at Ohum Healthcare Solutions, former Management Director at Deutsche Bank
Mr Umakant Jayaram Public Interest Director
Group, former Executive Director at JP Morgan
Management Trustee in ISMW, Board Director in Ananya Finance for Inclusive Growth, TFC and Gujarat
Ms Jayshree Vyas Public Interest Director
Urban Cooperative Bank Federation
Justice Shiavax Jal
Public Interest Director Former Chief Justice of Punjab & Haryana High Court
Vazifdar
Dr Padmini Srinivasan Public Interest Director Faculty at IIMB, Member of Academic oversight body of the international Integrated Reporting Council
Mr Nandkumar
Public Interest Director Former CEO of ReBIT's and Data Security Council of India
Saravade
Mr Jagannath Non-independent
MD of LIC
Mukkavilli Director
Source: Company, Nuvama Research
28 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Industry Outlook
Indian exchanges set to benefit from several macro positives
Under penetration of capital markets: India has a moderate M-cap to GDP ratio
of 125% compared with 259% for Switzerland, 196% for the US and 147% for Japan,
which reflects room for upside. A consistent increase in GDP along with higher share
of corporate earnings and a rise in the number of listed companies should lead to
market expansion. Moreover, after covid, India experienced a surge in its m-cap to
over 100% facilitated by an increase in retail participation and market valuation.
300
259
240
196
183
180 147
(%)
125
120 99
82 80
59 53
60
18
0
Australia
India
Germany
Switzerland
US
China
Japan
Luxembourg
Taiwan
Singapore
South Africa
Source: Bloomberg, Nuvama Research
150
123
120 113
104
95
89
90 79 77
73 76
70 69
(%)
63
60
30
-
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 29
BSE
35 13
10.8
28 8.6 10
8.2
7.6
6.9
21 8
(INR tn)
(%)
14 4.1 5
3.5
7 3
16.1 20.6 22.6 23.2 30.7 26.1 29.7
0 0
FY17 FY18 FY19 FY20 FY21 FY22 FY23
100
80
58
(As % of savings)
73 68 69 67 69
60 79 79 76
40
20 42
27 32 31 33 31
21 21 24
0
FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23
Turnover velocity set to improve: Turnover velocity is the ratio between cash
market turnover of domestic shares and their market capitalisation. A higher
turnover velocity reflects liquidity in the market that leads to better price discovery.
The turnover velocity at NSE is at 45%, which is considerably lower than that of other
exchanges, and offers scope of more investor participation. Given higher retail and
institutional participation driven by technological advancement and growth of the
Indian economy, the turnover velocity is set to accelerate in future.
30 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
450
395
360
270
(%)
172
180
104
90 60 57 47 45 37
Canada
India
Germany
China
Korea
Japan
Hongkong
Euronext
Source: WEF, Nuvama Research
Demat accounts leapfrog FY20 onwards: Demat accounts have taken a notable leap
after FY20 reaching 182mn by Nov-24 and have surged 4x from FY19 indicating
strong capital market participation by retail investors thanks to digital discount
brokers actively targeting new demographics, leveraging rising smartphone
penetration and public digital infrastructure (eKYC) for fast on boarding. Various
financial influencers spread financial awareness, and regulators promote
transparency and efficiency to boost investor confidence to boost the participation
of the investors.
Demat accounts surge post-FY20
200 182
160 151
114
120
(mn)
90
80
55
36 36 41
40 28 32
23 25
0
FY25TD
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 31
BSE
6.0 5.6
5.2
4.8
4.8 4.4
4.0
3.5
3.6 3.1
(mn)
2.7
2.2
2.4
1.7
1.2
1.2 0.9
0.6
0.3
0.0 0.1 0.1
-
Jul-23
Jul-24
Jun-23
Jun-24
Aug-24
May-23
Nov-23
Apr-24
May-24
Aug-23
Sep-23
Dec-23
Jan-24
Feb-24
Mar-24
Sep-24
Oct-23
Source: BSE, Nuvama Research
India’s cash equity ADTV has grown at an FY14–24 CAGR of 21% to INR 883bn,
whereas equity index options ADPTV has grown at an FY14–24 CAGR of 50.6% to
INR582bn. India’s futures ADTV has grown at an FY14–24 CAGR of 15.2% to
INR1,341bn in FY24. BSE has ~7% market share in cash ADTV, 12% in equity index
options ADPTV and only 0.1% in futures ADTV.
India’s cash equity ADTV grows at an FY14–24 CAGR of 21% to INR 883bn
1,400 90
71.8
1,120 62.6 66
49.9
840 44.1 42
(INR bn)
38.5
(%)
560 21.2 18
11.2 7.5
0.7 4.0
280 (5.6) (18.4) (6)
131 213 201 244 338 352 391 672 722 589 883 1,273
0 (30)
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25E
32 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
(INR bn)
(%)
630 668
500 6.4
548
6.2
250 6.0
54 66 88
42 41
- 5.6
FY21 FY22 FY23 FY24 FY25TD
NSE BSE BSE market share (%)
Source: Company, Nuvama Research
Industry equity index options ADPTV logs 50.6% CAGR over FY14–24
600 190
140.9
480 150
123.1
360 110
(INR bn)
86.2
(%)
68.4
240 70
31.9 30.9 32.7 39.0 32.6
120 12.3 13.9 30
(1.3)
10 11 14 14 19 26 44 106 236 439 582 662
0 (10)
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Equity Index Options ADPTV (INR bn) YoY Growth (%) FY25E
Source: Company, Nuvama Research
BSE gains ~12% market share as of Nov-24 in equity index options ADPTV
600 562 599 15
11.7
480 439 12
360 9
(INR bn)
(%)
236
240 6
106 3.4
120 79 3
20
0 0 0
0 0.0 0.0 0.0 0
FY21 FY22 FY23 FY24 FY25TD
NSE BSE BSE market share (%)
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 33
BSE
1,200 50
33.0
24.2 24.5
900 30
(INR bn)
17.1
(%)
18.0 9.0
5.3
600 (2.1) 0.2 10
(3.6) (4.5)
300 (10)
325 513 502 624 830 874 875 1,0901,1881,1451,3411,280
0 (30)
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25E
Futures ADTV (INR bn) YoY Growth (%)
Source: Company, Nuvama Research
1,600 0.4
1,340
1,188 1,145
1,200 1,090 0.3
(INR bn)
(%)
800 0.2
34 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Additional Data
Management Holdings – Top 10*
MD & CEO Shri Sundararaman Ramamurthy % Holding % Holding
CRO Ms. Kamala K. Life Insurance 5.60 HSBC Small Cap 1.29
Siddharth Balac 3.69 Invesco India M 1.24
CFO Shri Deepak Goel
Tata Aia Life I 2.28 New World Fund 1.19
Nippon Life Ind 1.86 S Gopalakrishna 1.18
Auditor M/s. S. R. Batliboi & Co. LLP Mukul Mahavir A 1.48 Zerodha Broking 1.08
*Latest public data
4640 30
24
3480
(INR)
(Mn)
18
2320
12
1160 6
0 0
Nov-24
Nov-22
Nov-23
Jan-22
Jan-23
Jan-24
Jul-22
Jul-23
Jul-24
May-22
Sep-22
May-23
May-24
Mar-22
Mar-23
Sep-23
Mar-24
Sep-24
Reduce <-5% 27
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 35
BSE
DISCLAIMER
Nuvama Wealth Management Limited (defined as “NWML” or “Research Entity”) a company duly incorporated under the Companies Act, 1956 (CIN No L67110MH1993PLC344634) having
its Registered office situated at 801- 804, Wing A, Building No. 3, Inspire BKC, G Block, Bandra Kurla Complex, Bandra East, Mumbai – 400 051 is regulated by the Securities and Exchange
Board of India (“SEBI”) and is licensed to carry on the business of broking, Investment Adviser, Research Analyst and other related activities. Name of Compliance/Grievance officer: Mr. Atul
Bapna, E-mail address: complianceofficer.nwm@nuvama.com Contact details +91 (22) 6623 3478 Investor Grievance e-mail address- grievance.nwm@nuvama.com
This Report has been prepared by NWML in the capacity of a Research Analyst having SEBI Registration No.INH000011316 and Enlistment no. 5723 with BSE and distributed as per SEBI
(Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any
transaction. Securities as defined in clause (h) of section 2 of the Securities Contracts (Regulation) Act, 1956 includes Financial Instruments and Currency Derivatives. The information
contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as
the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary
to arrive at an independent evaluation of an investment in Securities referred to in this document (including the merits and risks involved), and should consult his own advisors to determine
the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors.
This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly
in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a
citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which
would subject NWML and associates, subsidiaries / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain
jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this
report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. NWML reserves
the right to make modifications and alterations to this statement as may be required from time to time. NWML or any of its associates / group companies shall not be in any way responsible
for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NWML is committed to providing independent and transparent
recommendation to its clients. Neither NWML nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct,
indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprieta ry trading and investment
businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance .The
disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the
report. The information provided in these reports remains, unless otherwise stated, the copyright of NWML. All layout, design, original artwork, concepts and other Intellectual Properties,
remains the property and copyright of NWML and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders.
NWML shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason including network (Internet) reasons or snags in the system, break
down of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the NWML to present the data. In no event
shall NWML be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data
presented by the NWML through this report.
We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the
same time. We will not treat recipients as customers by virtue of their receiving this report.
NWML and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the
Securities, mentioned herein or (b) be engaged in any other transaction involving such Securities and earn brokerage or other compensation or act as a market maker in the financial
instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with
respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. (c) NWML may have proprietary
long/short position in the above mentioned scrip(s) and therefore should be considered as interested. (d) The views provided herein are general in nature and do not consider risk appetite
or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation
to do business with NWML (e) Registration granted by SEBI and certification from NISM in no way guarantee performance of NWML or provide any assurance of returns to investors and
clients.
NWML or its associates may have received compensation from the subject company in the past 12 months. NWML or its associates may have managed or co-managed public offering of
securities for the subject company in the past 12 months. NWML or its associates may have received compensation for investment banking or merchant banking or brokerage services from
the subject company in the past 12 months. NWML or its associates may have received any compensation for products or services other than investment banking or merchant banking or
brokerage services from the subject company in the past 12 months. NWML or its associates have not received any compensation or other benefits from the Subject Company or third party
in connection with the research report. Research analyst or his/her relative or NWML’s associates may have financial interest in the subject company. NWML and/or its Group Companies,
their Directors, affiliates and/or employees may have interests/ positions, financial or otherwise in the Securities/Currencies and other investment products mentioned in this report. NWML,
its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the
time of publication of research report or at the time of public appearance.
Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange rates can be volatile and are subject to large fluctuations; ( ii)
the value of currencies may be affected by numerous market factors, including world and national economic, political and regulatory events, events in equity and debt markets and changes
in interest rates; and (iii) currencies may be subject to devaluation or government imposed exchange controls which could affect the value of the currency. Investors in securities such as
ADRs and Currency Derivatives, whose values are affected by the currency of an underlying security, effectively assume currency risk.
NWML’s Associates may have actual / beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of
research report.
Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication
of research report: No
NWML has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No
Subject company may have been client during twelve months preceding the date of distribution of the research report.
There were no instances of non-compliance by NWML on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years.
A graph of daily closing prices of the securities is also available at www.nseindia.com
36 Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities
BSE
Analyst Certification:
The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities,
and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
Additional Disclaimers
This report is intended for distribution by NWML only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and
interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above,
then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the
Major Institutional Investor.
In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional
Investors, NWML has entered into an agreement with a U.S. registered broker-dealer, Nuvama Financial Services Inc. (formerly Edelweiss Financial Services Inc.) ("NFSI"). Transactions in
securities discussed in this research report should be effected through NFSI.
In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within
Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the “Order”); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated
associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as “relevant persons”).
This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this research report relates is available only
to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This
research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person.
This report is intended for distribution by NWML only to "Permitted Clients" (as defined in National Instrument 31-103 ("NI 31-103")) who are resident in the Province of Ontario, Canada
(an "Ontario Permitted Client"). If the recipient of this report is not an Ontario Permitted Client, as specified above, then the recipient should not act upon this report and should return the
report to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any Canadian person.
NWML is relying on an exemption from the adviser and/or dealer registration requirements under NI 31-103 available to certain international advisers and/or dealers. Please be advised
that (i) NWML is not registered in the Province of Ontario to trade in securities nor is it registered in the Province of Ontario to provide advice with respect to securities; (ii) NWML's head
office or principal place of business is located in India; (iii) all or substantially all of NWML's assets may be situated outside of Canada; (iv) there may be difficulty enforcing legal rights against
NWML because of the above; and (v) the name and address of the NWML's agent for service of process in the Province of Ontario is: Bamac Services Inc., 181 Bay Street, Suite 2100, Toronto,
Ontario M5J 2T3 Canada.
INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS. READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE
INVESTING.
ABNEESH
Digitally signed by ABNEESH KUMAR ROY
DN: c=IN, o=Personal,
KUMAR
2.5.4.20=e648fc28137c6fa4c0e6296c524ee
518d54fd4f7ba4be4d07cb750c531c68e2c,
Head of Research Committee postalCode=400098, st=Maharashtra,
serialNumber=7370c9de10fb28bbf7cbc6f7
ROY
1afe3cfe848fa7245a8d681629dc3093fb2a8
ea9, cn=ABNEESH KUMAR ROY
Abneesh.Roy@nuvama.com Date: 2025.01.14 17:11:08 +05'30'
Adobe Acrobat version: 2024.005.20320
Nuvama Research is also available on www.nuvamaresearch.com, Bloomberg - NUVA, Thomson Reuters, and Factset Nuvama Institutional Equities 37
Nuvama Institutional Equities, Inspire BKC, G Block, 8th Floor, Bandra Kurla Complex, Mumbai 400 051
Tel: +91 22 6620 3030. Email: research@nuvama.com